Research Output per year
Fingerprint Dive into the research topics where Seok-Gu Kang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 5 Similar Profiles
Glioblastoma
Medicine & Life Sciences
Glioma
Medicine & Life Sciences
temozolomide
Medicine & Life Sciences
Mesenchymal Stromal Cells
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Neoplastic Stem Cells
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2000 2019
Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma
Joo, B., Han, K., Ahn, S. S., Choi, Y. S., Chang, J. H., Kang, S-G., Kim, S. H., Zhou, J. & Lee, S. K., 2019 Jan 1, In : European Radiology.Research output: Contribution to journal › Article
Amides
Glioma
Protons
Mutation
Survival
Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: Clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era
Byun, H. K., Kim, N., Yoon, H. I., Kang, S-G., Kim, S., Cho, J., Baek, J. G., Chang, J. H. & Suh, C-O., 2019 Mar 27, In : Radiation Oncology. 14, 1, 51.Research output: Contribution to journal › Article
Open Access
Intensity-Modulated Radiotherapy
Lymphopenia
Glioblastoma
temozolomide
Radiation
Combined treatment with 2′-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness
Jeong, H., Park, J., Shim, J. K., Lee, J. E., Kim, N. H., Kim, H. S., Chang, J. H., Yook, J. I. & Kang, S-G., 2019 Jan 1, In : Journal of Neuro-Oncology.Research output: Contribution to journal › Article
temozolomide
Glioblastoma
Epithelial-Mesenchymal Transition
Heterografts
Catenins
1
Citation
(Scopus)
Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
Park, J., Kim, C. G., Shim, J. K., Kim, J. H., Lee, H., Lee, J. E., Kim, M. H., Haam, K., Jung, I., Park, S. H., Chang, J. H., Shin, E. C. & Kang, S-G., 2019 Jan 2, In : OncoImmunology. 8, 1, e1525243.Research output: Contribution to journal › Article
temozolomide
Glioblastoma
Therapeutics
Neoplasms
Immunologic Memory
2
Citations
(Scopus)
Immune checkpoint inhibitor-induced reinvigoration of tumor-infiltrating CD8+ T cells is determined by their differentiation status in glioblastoma
Park, J., Kwon, M., Kim, K. H., Kim, T. S., Hong, S. H., Kim, C. G., Kang, S-G., Moon, J. H., Kim, E. H., Park, S. H., Chang, J. H. & Shin, E. C., 2019 Apr 15, In : Clinical Cancer Research. 25, 8, p. 2549-2559 11 p.Research output: Contribution to journal › Article
Glioblastoma
CTLA-4 Antigen
T-Lymphocytes
Tumor-Infiltrating Lymphocytes
Neoplasms
Press / Media
Korea Advanced Institute of Science and Technology Granted Patent for Pharmaceutical Composition for Treatment of Cancer Comprising RNA Oligonucleotide
19/7/3
1 item of Media coverage
Press/Media: Press / Media
Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study
18/10/2
1 item of Media coverage
Press/Media: Press / Media
A Breakthrough for Understanding Glioblastoma: Origin Cell...
18/8/9
1 item of Media coverage
Press/Media: Press / Media
Origin Cells for Deadly Brain Tumors Identified
18/8/6
1 item of Media coverage
Press/Media: Press / Media
Origin cells for deadly brain tumours identified
18/8/3
1 item of Media coverage
Press/Media: Press / Media